510(k) K922284— ELEGANCE FT4 ELISA

Substantially Equivalent

Bioclone Australia Pty , Ltd.

Clearance details

Applicant: Bioclone Australia Pty , Ltd.
Product code: Code CEC
Advisory panel: Clinical Chemistry
Date received: 1992-05-15
Decision date: 1992-07-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Washington, DC, US

Adverse events under product code CEC

product code CEC

Malfunction: 899
Total: 899

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.